EBO
EBOS FPO NZ [EBO]
Healthcare · ASX Small Cap
$18.8900 +0.6%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical74
Catalyst66
Sentiment50
Fundamental100
Momentum39
Risk Gate50
Get alerts when EBO's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is picking up steam
- Volume surging at 4.5x normal while price climbs — real buying conviction behind this move
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Cash positive / operating cashflow positive
- Low P/S ratio (0.3x)
- Moderate revenue growth (+13%)
- Piotroski F-Score strong (8/9, low-confidence approx)
- EPS estimates revised upward (+10pts)
- Near 52-week low (5% of range)
- New substantial holder(s) (1)
- CANSLIM C: Positive EPS growth (13% QoQ)
- CANSLIM I: Institutional ownership (26%)
- Sentiment is mixed — no strong consensus either way
- Poor risk-adjusted returns — Sharpe of -2.3 means lots of volatility for not much reward
- RBA hiking (-3pts)
- Technical-fundamental alignment: quality + trend
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 41% over the past year
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about EBO
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE NZX Capital Change Notice
NONE Notification regarding unquoted securities - EBO
NONE Update - Dividend/Distribution - EBO
HIGH Becoming a substantial holder
Recent ASX Announcements
| 2026-03-24 | NZX Capital Change Notice |
| 2026-03-24 | Notification regarding unquoted securities - EBO |
| 2026-03-23 | Becoming a substantial holder |
| 2026-03-20 | Update - Dividend/Distribution - EBO |
| 2026-03-20 | NZX Performance Rights Update |
Key Metrics
$3.9B
Market Cap
254K
Avg Volume
4.5x
Vol Ratio
$17.78 — $38.23
52-Week Range
0.5%
Short Interest
N/A
Cash Runway
9.0%
ROE
1.8%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | weak | EPS Growth: 13% |
| A | Annual Earnings | neutral | CAGR: 1% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 94% |
| L | Leader vs Laggard | laggard | RS: -4 |
| I | Institutional Sponsorship | pass | Inst: 26% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #35 of 117 · Sector avg: 46
View all Healthcare signals →Track EBO and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required